CMND

Clearmind Medicine Inc. CMND

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$31.0K total
CITADEL ADVISORS LLC
$25.8KNew
AdvisorShares Investments LLC
$2.6K-84.1%
MORGAN STANLEY
$1.5KNew
ROYAL BANK OF CANADA
$1.0K+1950.0%
HRT FINANCIAL LP
$77+120.9%
Caitong International Asset Management Co., Ltd
$2New
See all 6 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q1 2026
EDGAR

EPS (Diluted)

Q1 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CMND

Earnings Per Share

13fpro.ai/company/CMND

Loading ratio trend…

CMND insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Clearmind Medicine Inc. (CMND): stock profile, AI score and financials

Clearmind Medicine Inc. (CMND) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CMND is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of CMND by reported 13-F value include CITADEL ADVISORS, AdvisorShares Investments, MORGAN STANLEY, based on the most recent SEC filings. CMND trades on the Nasdaq exchange and files with the SEC under CIK 1892500. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CMND daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Clearmind Medicine Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1892500 →